See also this year's filing and all EDGAR filings for this company.
PDF Report 0001600132_2021_Bellerophon_Therapeutics_Inc.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -1800000} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001600132, Bellerophon Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 48,080,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 169,000 |
| 3 | remainder_Assets | 1,990,000 |
| 4 | LiabilitiesCurrent | 10,433,000 |
| 5 | LiabilitiesNoncurrent | 956,000 |
| 6 | remainder_Liabilities | 601,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,822,404 |
| 9 | ResearchAndDevelopmentExpense | 15,784,087 |
| 10 | remainder_Expenses | -1,856,485 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 396,409 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 50,239,000 |
| 1 | Liabilities | 11,990,000 |
| 2 | Expenses | 21,750,006 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 38,249,000 |
| 5 | NetIncome | -21,353,597 |
| 6 | ComprehensiveNetIncome | -21,353,597 |
| 7 | BaseVar | 42,187,708 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.99 |
| 9 | EconomicCapitalRatio | 3.02 |
Edgar->Model Mapping
Feature Distribution
Change over Time
